EP3806955
GLP-1 viðtakaörvar og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.6.2019EP published:
31.5.2023EP application number:
19733151.5
EP translation filed:
26.6.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
10.6.2039Expiry date:
10.6.2026Next due date:
30.6.2026
Title in English:
GLP-1 RECEPTOR AGONISTS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
11.6.2019EP application
31.5.2023EP Publication
26.6.2023Translation submitted
15.8.2023Registration published
10.6.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
ASPNES, Gary ErikAddress:
88400 Biberach an der Riss, DE
Name:
BAGLEY, Scott W.Address:
Groton, CT 06340, US
Name:
CURTO, John M.Address:
Groton, CT 06340, US
Name:
EDMONDS, David JamesAddress:
Cambridge, MA 02139, US
Name:
FLANAGAN, Mark E.Address:
Groton, CT 06340, US
Name:
FUTATSUGI, KentaroAddress:
Cambridge, MA 02139, US
Name:
GRIFFITH, David A.Address:
Cambridge, MA 02139, US
Name:
HUARD, KimAddress:
Berkeley, CA 94703, US
Name:
LIAN, YajingAddress:
Groton, CT 06340, US
Name:
LIMBERAKIS, ChrisAddress:
Groton, CT 06340, US
Name:
LONDREGAN, Allyn T.Address:
Groton, CT 06340, US
Name:
MATHIOWETZ, Alan M.Address:
Cambridge, MA 02139, US
Name:
PIOTROWSKI, David W.Address:
Groton, CT 06340, US
Name:
RUGGERI, Roger B.Address:
Waterford, CT 06385, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862684696 PDate:
13.6.2018Country:
US
Number:
201962846944 PDate:
13.5.2019Country:
US
Number:
201962851206 PDate:
22.5.2019Country:
US
Classification
Categories:
A61P 3/10, C07D 413/14, C07D 405/12, A61K 31/496, C07D 405/14
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 30.6.2023
Expires: 10.6.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 13.5.2024
Expires: 10.6.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 30.5.2025
Expires: 10.6.2026
Payer: Árnason Faktor ehf.